Mold infections in lung transplant recipients

Pharmacology, Toxicology and Pharmaceutical Science

• Amphotericin 33%
• Aspergillosis 33%
• Aspergillus 66%
• Bronchiolitis Obliterans 33%
• Candidiasis 33%
• Cytomegalovirus Infection 33%
• Diseases 33%
• Fusarium 66%
• Immunoglobulin Deficiency 33%
• Infection 100%
• Infectious Agent 33%
• Invasive Aspergillosis 66%
• Mould 100%
• Mycosis 33%
• Retrospective Study 33%
• Scedosporium 66%
• Squamous Cell Carcinoma 33%
• Syndrome 33%
• Voriconazole 66%
• Zygomycetes 66%

Keyphrases

• Amphotericin B 16%
• Anti-mold 16%
• Antifungal Prophylaxis 33%
• Aspergillus Infection 33%
• Aspergillus Species 16%
• Bronchiolitis Obliterans Syndrome 16%
• Candida Infection 16%
• Cytomegalovirus Infection 16%
• Drug Choice 16%
• Fungal Infection 16%
• Fusarium 33%
• Hypogammaglobulinemia 16%
• Invasive Aspergillosis 33%
• Lung Transplantation 100%
• Mold Infection 100%
• Parenchymal Disease 16%
• Pretransplant 16%
• Risk Factors 50%
• Scedosporium 33%
• Single Lung Transplantation 16%
• Squamous Cell Cancer 16%
• Transplant Center 16%
• Voriconazole 33%
• Zygomycetes 33%